Poster and Platform Presentations

Prospectively determining seizure-related injuries in epilepsy: Results from the first 14 months of systematic assessment.

Friedman D

High frequency EEG activity associated with ictal events in the TTX model of infantile spasms.

Frost J, Lee C, Hrachovy R, Swann J

Epilepsy and neurocysticercosis in Houston, Texas.

Kung D, Serpa-Alvarez J, Kass J, Friedman D

Influence of levodopa and psychotropic medication on emotional and physical symptoms of depression before and following STN-DBS for the treatment of Parkinson's disease.

Gallander KM, Strutt AM, Simpson R, Jankovic J, York MK

Alternating fluency performance following bilateral STN DBS for the treatment of Parkinson's disease.

Marshall DF, Williams AE, Strutt AM, Jankovic J, York MK

Small asymptomatic aneurysms do rupture. Relationship of growth to aneurysm rupture in asymptomatic aneurysms <=7mm: A Systematic Analysis of the Literature.

Chmayssani M, Rebeiz JG, Batjer HH, Bendok BR

MeCP2 regulation of GABAergic neuronal function modulates behavior and synaptic plasticity.

Chao H-T, Chen H, Samaco RC, Chahrour M, Xue M, Yoo J, Neul JL, Gong S, Heintz N, Ekker M, Rubenstein J, Noebels JL, Rosenmund C, Zoghbi HY

Functional correlation of brain loci during cognitive tasks in multiple sclerosis.

Helekar SA, Shin JC, Mattson BJ, Bartley K, Stosic M, Saldana-King T, Montague PR, Hutton GJ

Selective expression and cellular localization of pro-inflammatory chemokine ligand/receptor pairs in the sciatic nerves of a severe murine experimental autoimmune neuritis model of Guillain-Barré Syndrome.

Ubogu EE, Yosef N, Xia RH

Spontaneous epilepsy and neuronal hyperexcitability in Kv12.2 -/- mice.

Zhang X, Bertaso F, Yoo J, Schmedt C, Clancy S, Noebels JL, Jegla T

Deep brain stimulation in multiple sclerosis-related Holmes' tremor.

Bernitsas E, Hutton GJ, Rivera VM

Novel multifunctional drug D-264 for Parkinson's disease: Evidence of neuroprotective property in PD animal models induced by MPTP and lactacystin.

Li C, Biswas S, Xie WJ, Dutta AK, Le WD

Motor neuropathy in Fascioscapulohumeral Dystrophy (FSHD).

Shanina E, Mosier D, Smith RG

Correlation of daily energy expenditure with motor and non-motor symptoms of Parkinson's disease.

Trail M, Petersen N, Lai EC

Electrophysiological-pathologic correlations in severe murine experimental autoimmune neuritis.
[Previously Presented]

Xia RH, Yosef N, Ubogu EE

Development of a novel human in vitro blood-nerve barrier model.

Yosef N, Xia RH, Ubogu EE

Phenotypic characterization of the human blood-nerve barrier ex vivo.

Yosef N, Xia RH, Ubogu EE

Mitochondrial electron transport chain complex II and III deficiency myopathy: Case report.

Puwanant A, Hassan MO, Ubogu EE

Electrophysiologial-pathologic correlations in murine experimental autoimmune neuritis.

Ubogu EE, Yosef N, Xia RH

Effects of natalizumab on relapses and MRI outcomes in Hispanic patients with relapsing multiple sclerosis.

Herbert J, Rivera V, Ford C, Pace A, Hyde R

Final results from the Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis study.

Rivera V, Weinstock-Guttman B, Beagan J, Al-Sabbagh A, Bennett R, Dangond F

>> View platform presentation

Assessment of acute mild traumatic brain injury by quantitative EEG analysis — Mission Connect: Mild Traumatic Brain Injury Translational Research Consortium — The Integrated Clinical Protocol: Neurophysiology Core.

Mizrahi EM, Frost JD, Jr., Friedman DE, Hrachovy RA, Slater JD

Clinical depression, anxiety, and PTSD as risk factors for morbidity following coronary artery bypass grafting surgery.

Dao T, Nguyen Q, Chu D, Anderson T, Springer J, Collins R, Pastorek N

Association of trauma and PTSD with dementia and other physical illnesses in older veterans.

Qureshi S, Schulz P, Pyne J, Magruder K, Kimbrell T, Hudson T, Kunik M

Spanish translation and normative data for the Dementia Rating Scale, second edition.

Strutt AM, Ayanegui IG, York MK

Does diabetes mellitus alter the clinical course of vascular dementia?

Murthy S, Jawaid A, Shah S, Qureshi S, Shah J, Johnson M, Wilson A, Kalkonde Y, Kunik M, Schulz P

Effects of antiparkinsonian medications on forward and backward gait patterns in persons with Parkinson's disease (PD).

Bryant MS, Rintala DH, Fernandez AL, Hou JG, Lai EC, Protas EJ

Long-term deep brain stimulation for essential tremor: 12- year clinicopathologic follow up and literature review.

DiLorenzo DJ, Jankovic J, Simpson RK, Takei H, Powell SZ

Double-blind, randomized, placebo-controlled, cross-over trial of pregabalin in essential tremor.

Ferrara FM, Kenney C, Davidson AL, Shinawi L, Kissel AM, Jankovic J

Impact of STN-DBS on health-related quality of life in patients with Parkinson's disease.

Ferrara JM, Diamond A, Davidson A , Almaguer M, Jankovic J

Tourette syndrome in adults.

Gelineau-Kattner RN, Jankovic J, Davidson AL

Efficacy and safety of NT 201 (botulinum neurotoxin type A free from complexing proteins) in treatment-naive cervical dystonia patients.

Grafe S, Comella C, Jankovic J, Truong D, Hanschmann A

Efficacy and safety of NT 201, botulinum neurotoxin type A free from complexing proteins) in pre-treated cervical dystonia patients.

Grafe S, Comella C, Jankovic J, Truong D, Hanschmann A

A randomized, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome.

Jankovic J, Jimenez-Shahed J, Brown LW

Pilocarpine-induced myotic response is greater in PD than in MSA patients.

Lanzafame S, Mostile G, Contrafatto D, Raciti L, Sorbello V, Luca A, Nicoletti A, Zappia M

Transcription factor PITX3 in Parkinson's disease.

Le W, Nguyen D, Lin W, Rawal P, Ding Y, Xie W, Deng H, Jankovic J

Gait analysis is more sensitive than finger tapping or UPDRS motor scores in assessment of the motor response to levodopa in Parkinson's disease.

Moore ST, Shinawi L, Ondo WG

Correlation between Kinesia system assessments and clinical TETRAS scores in patients with essential tremor.

Mostile G, Giuffrida JP, A dam OR, Davidson A, Jankovic J

Intravenous iron dextran for severe refractory restless legs syndrome.

Ondo WG

Task specific writing tremor: Series and outcomes.

Ondo WG, Satija P, Ummat M

17-AAG protects against rotenone-induced apoptosis in SHSY5Y cells via HSP70 induction.

Pan T, Xie W, Jankovic J, Le W

Resveratrol, a polyphenol found in red wine, protects against rotenone-induced apoptosis through autophagy induction.

Pan T, Xie W, Le W, Jankovic J

The course of depressive symptoms in early Parkinson's disease.

Ravina B, Elm J, Camicioli R, Como P, Marsh L, Jankovic J, Weintraub D

Parkinson's disease – Characteristics of disease onset in a veteran population.

Sarwar AI, Lai EC

Mood differences between women diagnosed with psychogenic movement disorders and psychogenic seizures.

Strutt AM, Ferrara J, Hill S, York MK, Uber-Zak L, Fogel T, Jankovic J

Type and intensity of daily energy expenditures among Parkinson's disease patients based upon their body weight.

Trail M, Petersen NJ, Nelson N, Lai EC

Assessment of medical care for patients with Parkinson's disease during hospitalization.

Wu LJ, Ward CT, Moore S, Hou JG, Nelson N, Fincher L, Atassi F, Lai EC

Neuroprotection trials in Parkinson's disease.

Yaltho TC, Hart RG, Pearce LA, Ravina BM, Marler JR

Clinical and radiographic improvement of an acutely aggressive case of multiple sclerosis treated with cyclophosphamide.

Avila M, Prieto PG, Robles L, Hutton GJ, Rivera VM

Prevalence of sleep disorders in multiple sclerosis.

Avila M, Robles L, Prieto P, Bernitsas E, Stosic M, Hutton GJ, Rivera VM

Spasmodic dysphonia in MS: A rare symptom or a possible association?

Bernitsas E, Hutton GJ, Rivera VM

Seizures in MS patients: A retrospective study.

Bernitsas E, Stosic M, Hutton GH, Rivera VM

HALT-MS--Intense immunosuppression and stem cell transplantation for RRMS.

Hutton GJ, Bowen J, Forman S, Frohman E, Griffith L, Kraft G, Muraro P, Openshaw H, Popat U, Racke M, Sayre P, Stuve O, Wundes A, Nash R

Long-term sc IFN beta-1a treatment in RRMS: Cumulative dose effects.

Jeffery D, Rivera VM

Continuous vs non-continuous long-term sc IFN beta-1a treatment in RRMS.

Rivera VM, Jeffery D

Difusse white matter abnormalities and neurologic manifestations in a patient with anti-ro positive antibodies. Case Report..

Robles L, Prieto P, DeAlvare L, Hutton GJ, Rivera VM

Occurrence of herpes zoster in multiple sclerosis patients treated with natalizumab.

Robles L, Prieto P, Rivera VM, Hutton GJ

Clinical-electrophysiologic-pathologic correlations in severe murine experimental autoimmune neuritis.

Ubogu EE, Yosef N, Xia RH

Development of a human in vitro blood-nerve barrier model.

Ubogu EE, Yosef N, Xia RH

The written and oral administration of the Symbol Digit Modality Test in Huntington disease.

Adam O, Halton S, Mostile G, Jankovic J

How well does the ADAS-cog measure the spectrum of Alzheimer's disease severity? An item response theory analysis.

Benge J, Balsis S, Geraci L, Massman P, Doody R

The non motor staging of Parkinson's disease: Results from an international study.

Chaudhuri KR, Martinez-Martin P, Sherman R, Naidu Y, Odin P, Sethi K, Ondo W, Stocchi F, Schapira A, PD Non Motor Group

Polyarteritis nodosa-type vasculitis isolated to the central nervous system: A first case report of a fulminant primary CNS vasculitis variant.

Chern J, Kung D, Kass J

Efficacy and safety of NT 201 (neurotoxin free from complexing proteins) in cervical dystonia.

Comella C, Jankovic J, Truong D, Hanschmann A, Grafe S

Age at onset and pre- morbid IQ influence early progression rates in AD.

Doody R, Chan W, Pavlik V, Massman P, Darby E, Rountree S, Szigeti K

Material specific memory impairment is associated with unilateral cingulum bundle structural integrity in intractable temporal lobe epilepsy.

Dulay M, Verma A, Karmonik C, Xue Z, Strutt A, York M, Haykal H, Grossman R

Apocynin decreases consequences of nitric oxide synthase uncoupling in experimental neonatal hypoxia-ischemia.

Fabian R, Kent T

Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.

Ferrara JM, Adam OR, Ondo WG

Correlations of serum uric acid levels with Parkinson's disease symptom severity.

Hou JG, Lai EC

Efficacy and safety of NT 201 (botulinum neurotoxin free from complexing proteins) in blepharospasm.

Jankovic J, Comella C, Hanschmann A, Grafe S

A post-hoc analysis of cumulative dose effects of subcutaneous interferon beta-1a on clinical and MRI outcomes in relapsing-remitting multiple sclerosis: Results over the long term.

Jeffery D, Rivera V

Long-term effects of interferon beta-1a dose on relapse rate in relapsing-remitting multiple sclerosis: Results from a post- hoc analysis of PRISMS study data.

Jeffery D, Rivera V

An efficient and robust method for the fractional anisotropy analysis of white matter tracts based on automated template matching in talairach space.

Karmonik C, Dulay M, Verma A, York M, Grossman R

Toxoplasmosis myopathy as a manifestation of HIV immune reconstitution inflammatory syndrome.

Kung D, Hubenthal E, Shelburne S, Goodman J, Kwan J, Kass J

Survival among veterans with Parkinson's disease.

Kuo SH, Moore S, White D, Lai EC

ApoE genotype in ALS.

McDowell E, Jawaid A, Poon M, Rice L, Salamone A, Strutt A, York M, Appel S, Schulz P

Searching for unicorns: The neurologist as diagnostician for rare disorders.

Mosier D, Smith R

Rapamycin protects against rotenone-induced apoptosis through autophagy induction in SH-SY5Y cells.

Pan T, Xie W, Rawal P, Jankovic J, Le W

A controlled study of the long-term cognitive outcome of bilateral subthalamic nucleus deep brain stimulation.

Williams A, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK

Study of orthostatic regulation in patients with Parkinson's disease receiving deep brain stimulation.

Wu L, Hou JG, Lai EC

HALT MS – Phase II clinical trial of high dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation for active relapsing- remitting multiple sclerosis.

Wundes A, Bowen J, Kraft G, Hutton G, Openshaw H, Forman S, Frohman E, Griffith L, Muraro P, Racke M, Sayre P, Stuve O, Popat U, Nash R

Is there an association between PTSD and dementia?

Qureshi S, Schulz P, Pyne J, Magruder K, Kimbrell T, Hudson T, Kunik M

Anesthesiologist with muscle cramps.

Ansari S, Smyth S, Harati Y

A tale of two diseases.

Kung D, Harati Y

Myasthenia mimics.

Nord K, Mosier D

Muscular dystrophy with subacute onset.

Phan CI, Biliciler S, Harati Y

Another patient with burning feet.

Smyth S, Harati Y

A case of a painful leg.

Vullaganti M, Harati Y

A pilot study of executive functions in PTSD.

Benge J, Collins R, Kent T

Implementation of patient self-management programs among veterans in VA.

Damush, Anderson J, Bosworth H

Predictors of individual visual memory decline after right anterior temporal lobe resection.

Dulay MF, Levin HS, York MK, Mizrahi EM, Goldsmith IL, Goldman A, Verma A, Barnwell LF, Chen DK, Friedman DE, Grossman RG, Yoshor D

Systematic screening in a busy clinical setting improves identification of depression in people with epilepsy.

Friedman DE, Kung DH, Kass JS

Optimizing electromyography, chemical denervation, and percutaneous procedures of the pelvic floor with magnetic resonance imaging-based schematics.

Kass JS, Chiou-Tan FC, Harrell JS, Miller JS, Taber KH

Kcna1 is a novel candidate gene for sudden unexplained death in epilepsy (SUDEP).

Glasscock E, Yoo JW, Noebels JL

Alzheimer's disease as descent into randomness: Evidence from category fluency testing.

Lerner AJ, Albo Z, Messer J, Singh T, Woyczynski W

Marburg's disease and neuromyelitis optica in brother/sister.

Bernitsas E, Hutton GJ, Rivera VM

The ALS Cognitive Behavioral Screen (ALS CBS™): Phase II validation.

Woolley S, York MK, Strutt AM, Schulz PE, Katz J

Intracranial hemorrhage following intravenous tissue plasminogen activator use for stroke caused by infective endocarditis.

Bhuva P, Kuo S-H, Lopez GA, Hemphill JC

Voxel-based diffusion tensor imaging and diffusion tensor tractography for the evaluation of cognitive functioning in Parkinson's disease.

York M, Karmonik C, Wilde E, Kakkar E, Yallampalli R, Strutt A, Jankovic J, Grossman R

Coagulopathy is an independent predictor of inhospital mortality in patients with acute subdural hematoma.

Bershad EM, Farhadi S, Suri MF, Feen ES, Hernandez OH, Selman WR, Suarez JI

Higher uric acid levels and diuretics uses are associated with lower prevalence of Parkinson's disease (PD).

Hou JG, Lai EC

Short-term and long-term improvement by pramipexole in restless leg syndrome animal model.

Lou FF, Zhu W, Xie W, Ondo W, Le W

Altered age of onset in Alzheimer's disease with diabetes mellitus.

Shirani P, Salamone AR, Strutt AM, Schulz PE

Is frontal dysfunction associated with dysarthria in patients with Amyotrophic Lateral Sclerosis (ALS)?

Sterling LE, Salamone AR, Mosnik DM, Appel SH, Strutt AM, Schulz PE

Thalamic endogenous opioids are decreased in restless legs syndrome: A post-mortem study.

Walters AS, Ondo W, Zhu W, Le WD

Progressive DA neuron degeneration induced by targeting administration of proteasome inhibitor in SN.

Xie W, Zhu W, Pan T, Jankovic J, Le W

Menstrual cycle and menopause in patients with multiple sclerosis. How do these affect the symptoms of disease?

Avila M, Suarez GA, Brandt D, Ramirez J, Hutton GJ, Rivera VM

Longitudinal individualized analysis of computer-based cognitive rehabilitation in multiple sclerosis.

Chaliman RT, Perez FI, Suarez GA, Rivera VM, Hutton GJ

RENEW study update XVIII: Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis.

Rivera V, AL-Sabbagh A, Bennett R, Coyle P, Elias S, Mikol D, Panitch H, Rolak LA, Sheremata W, Weinstock-Guttman B, Fox E, for the RENEW Study Group

Magnetic resonance imaging findings in patients with clinically isolated syndrome suggestive of multiple sclerosis.

Suarez GA, Avila M, Brandt D, Rivera VM, Hutton GJ

Kcna1 is a novel candidate gene for sudden unexplained death in epilepsy (SUDEP).

Glasscock E, Yoo JW, Noebels JL

Eighteen-month data from an open-label extension of a one-year controlled trial of dimebon in patients with mild-to-moderate Alzheimer's disease.

Cummings J, Doody RS, Gavrilova S, Sano M, Aisen P, Seely L, Hung D

Interrater reliability between expert and nonexpert physicians in the assessment of amnestic MCI in the community setting.

Doody RS, Ferris SH, Salloway S, Meuser TM, Murthy AK, Li MC, Goldman R

Dimebon improves cognition, function, and behavior in mild and moderate Alzheimer's disease: Results by severity of a one-year, double-blind, placebo-controlled study.

Doody RS, Gavrilova S, Thomas R, Aisen P, Bachurin S, Seely L, Hung D

Mapping of Alzheimer disease stages using the MMSE: Effects of ethnicity and education.

Lerner AJ, Albo Z, Sami SA, McClendon MJ, Ogrocki PK, Singer M, Smyth KA

The effects of donepezil on Alzheimer's disease progression monitored by MRI.

Murthy AK, Schuff N, Suhy J, Doody RS, Goldman R

Persistent antidementia drug treatment and survival in an Alzheimer's disease (AD) cohort.

Rountree S, Pavlik V, Chan W, Doody RS

The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): Effect of atorvastatin on Alzheimer's disease progression by APOE4 genotype.

Sparks L, Kivipelto M, Doody RS, Waters D, Jones RW, Feldman H, Pickering E, Hu X, Hall S, Breazna A, DeMicco DA, Hey-Hadavi J, Schindler RJ

Unusual motor-phonic tic mimicking essential palatal myoclonus (EPM).

Adam OR, Jankovic J

Correlation between clinical rating of parkinsonian and essential tremor and quantitative assessments.

Aguilar LG, Giuffrida JP, Heldman DD, Jankovic J

Exploring the relationship between drug-induced parkinsonism and tardive dyskinesias.

Aguilar Tabora LG, Ondo WG

Interrater reliability of dynamic balance in persons with Parkinson's disease.

Bryant MS, Fernandez AL, Hou JG, Rintala DH, Lai EC, Protas EJ

The essential tremor rating assessment scale (TETRAS).

Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos J, Louis E, Lyons K, Ondo WG, Pahwa R, Sethi K, Stern M, Tanner C, Tarsy D, Tintner R, Watts R, Tremor Research Group

Factors predicting adverse effects to subcutaneous apomorphine.

Ferrara J, Ondo WG

Spinocerebellar Ataxia 8: Variable phenotype and unique pathogenesis.

Gupta A, Jankovic J

Rotigotine 24h transdermal patch is effective in the treatment of idiopathic RLS: Results of a 6-month, multicenter, double-blind, placebo-controlled US trial.

Hening WA, Allen R, Becker PM, Bogan RK, Fry JM, Keffel J, Kudrow DB, Lesh KW, Ondo WG, Schollmayer E, Vrooman P, Walters A, Winkelman JW

Higher serum uric acid levels in patients with essential tremor compared to Parkinson's disease.

Hou JG, Lai EC

Evaluation of a Parkinson's disease screening questionnaire for use in a community-based setting.

Hunter CB, Aguilar LG, Nashatizadeh MM, Lay LF, Jankovic J

The role of dopaminergic medication doses in impulse control disorders (ICD) in Parkinson's disease (PD).

Jimenez-Shahed J, Baker K, Davidson A, Jankovic J

Topiramate in treatment of Tourette's syndrome (TS).

Kuo SH, Jimenez-Shahed J

Expanded study of NURR1 gene expression in patients with Parkinson's disease.

Le WD, Pan T, Xie W, Huang M, Xu P, Zhu W, Zhang X, Deng H, Jankovic J

Ambulatory monitoring of motor fluctuations and freezing of gait: Objective assessment of the efficacy of pharmacological treatments in Parkinson's disease.

Moore ST, MacDougall HG, Ondo WG

Usefulness of [123I]FP-CIT striatal asymmetry index as specific tool to differenziate Parkinson's disease from vascular parkinsonism.

Mostile G, Nicoletti A, Contrafatto D, Lanzafame S, Raciti L, Sorbello V, Bruno E, Dibilio V, Distefano A, Zappia M

Deep brain stimulation of the subthalamic nucleus for peripherally-induced parkinsonism.

Nashatizadeh MM, Jankovic J

A randomized, double-blind, placebo-controlled study of atomoxetine for freezing of gait in Parkinson's disease.

Nashatizadeh MM, Jimenez JE, Davidson AL, Jankovic J

A self-management educational intervention for veterans and spouses living with Parkinson's disease: A pilot study.

Nelson ND, Moore S, Lai EC

Tolerability and efficacy of switching from swallowed selegiline to zydis selegiline (Zelapar®) in patients with Parkinson's disease.

Ondo WG, Hunter CB, Davidson A, Isaacson SH, Silver DE, Stewart RM, Tetrud JW

Memantine (Namenda®) for non-motor features of Parkinson's disease: A double blind placebo controlled trial.

Ondo WG, Shinawi L, Davidson A

Rapamycin rescues lactacystin-induced dopaminergic neuron injury in vivo.

Pan T, Xie W, Jankovic J, Le WD

Association between laterality (right or left) of onset of motor symptoms and degree of speech impairment in veterans with Parkinson's disease (PD).

Sarwar AI, Lai EC

Deep brain stimulation (DBS) parameters and gait in Parkinson's disease (PD).

Sarwar AI, Lai EC

Botulinum toxin A in electrical injury-induced cervical myoclonus.

Sitburana O, Ondo WG

Neuropsychological functioning of Parkinson's disease patients two years post subthalamic nucleus deep brain stimulation surgery.

Strutt AM, Jankovic J, York MK

Experience with MRI safety and DBS: Data from the National Parkinson Foundation Centers of Excellence.

Tagliati M, Jankovic J, Koss AM, Pagan F, Okun MS, National Parkinson Foundation DBS Working Group

Is depression related to quality of life (QOL) and activities of daily living (ADL) in veterans with Parkinson's disease (PD)?

Trail M, Nelson N, Moore S, Petersen N, Lai EC

Silent MRI white matter lesions in patients with CIS suggestive of multiple sclerosis.

Suarez-Zambrano GA, Ramirez J, Avila M, Brandt D, Escobar BH, Hutton GJ, Rivera VM

Volume and nature of patient telephone calls in a large movement disorders center.

Adam OR, Aguilar Tabora LG, Ferrara J, Nashatizadeh M, Jankovic J

Characteristics of archimedean spiral drawing in patients with psychogenic tremor.

Aguilar Tabora LG, Davidson A, Jankovic J, Ondo WG

Retinal microperimetry as a means to assess visual field expansion in visual restoration therapy.

Chmayssani M, Minzer B, Saxena N, Arogyasami R, Lazar R, Greenstein VC, Marshall RS

Site performance in an investigator-run multiple sclerosis clinical trial.

Cohen J, Imrey P, Calabresi P, Chakraborty S, Edwards K, Eickenhorst T, Felton W, Fisher E, Fox R, Goodman A, Hara-Cleaver C, Hutton G, Mandell B, Scott T, Zhang H for the ACT

Inter-rater reliability between expert and nonexpert physicians in the diagnosis of amnestic MCI in the community setting.

Doody RS, Ferris S, Salloway S, Meuser T, Murthy A, Li MC, Goldman R

Dimebon improves patient function and decreases caregiver assistance time in Alzheimer's disease: One-year clinical trial results.

Doody RS, Gavrilova S, Aisen P, Hirmand M, Sano M

Morbidity associated with psychogenic movement disorders in children.

Ferrara JM, Jankovic J

Phenomenology of psychogenic movement disorders in children.

Ferrara JM, Jankovic J

Dimebon improves memory, orientation, language, and praxis in patients with mild to moderate Alzheimer's disease: Results of a one-year placebo-controlled study.

Ferris S, Doody R, Gavrilova S, Sano M, Aisen P, Seely L

Injuries in phramacoreistant epilepsy: A comparison of temporal and extratemporal epilepsy patients.

Friedman DE, Gilliam FG

Neurocysticercosis and epilepsy in a county hospital in Houston, Texas.

Friedman DE, Wright R, Kass JS

New version of the UPDRS (MDS-UPDRS): Factor analysis.

Goetz CG, Tilley BC, Shaftman SR, Fahn S, Martinez-Martin P, Poewe W, et al.

CNS vasculitis as a manifestation of systemic sclerosis.

Goldsmith CE, Kass JS

Previous traumatic brain injury may be a risk factor of mood disorders in Parkinson's disease.

Hou JG, Lai, EC

Craving for sweets and other compulsive behaviors in patients with Parkinson's disease.

Jimenez-Shahed J, Calhoun K, Davidson A, Jankovic J

Acamprosate improves impulse control disorders in Parkinson's disease.

Jimenez-Shahed J, Hunter CB, Jankovic J

Brain activation in Parkinson's disease during a functional magnetic resonance imaging set shifting task: Preliminary findings.

Karmonik C, Grossman RG, York MK

Phase II clinical trial (HALT-MS: Immune tolerance network) of high dose immunosuppressive therapy (HDIT) and autologus hematopoetic stem cell transplantation (AHSCT) for active relapsing-remitting (RR) multiple sclerosis (MS): Early results.

Kraft GH, Bowen JD, Openshaw H, Forman SJ, Frohman EM, Griffith LM, Hutton GJ, Muraro PA, Popat U, Racke MK, Sayre P, Stuve O, Wundes A, Nash RA

Successful treatment of cognitive decline in Sneddon syndrome associated with hepatitis C with cyclophosphamide.

Kuo SH, Strutt AM, York MK, Kass JS

Characteristics and co-morbidities of patients with movement disorders and melanoma.

Lai EC, Moore S

Treatment of freezing of gait in Parkinson's disease with deep brain stimulation of the pedunculopontine nucleus.

Nashatizadeh M, Jankovic J

A single dose, placebo controlled, cross-over trial comparing the latency to onset of orally disintegrating (OD) levodopa (Parcopa) versus oral (PO) levodopa.

Ondo WG, Shinawi LM, Moore S

Role of deferoxamine and autophagy induction in rotenone-induced apoptosis.

Pan T, Li X, Xie W, Jankovic J, Le WD

Vitamin E use is associated with improved survival in an AD cohort.

Pavlik VN, Doody RS, Rountree SD, Darby EJ

Diabetes mellitus: Risk or protective factor in ALS?

Salamone AR, Wheaton M, McDowell E, Strutt AM, Schulz PE

Changes in emotional versus physical symptoms of depression following sub-thalamic nucleus deep brain stimulation for Parkinson's disease.

Strutt AM, York MK, Jankovic J

Frequency and severity of restless legs syndrome in multiple sclerosis: A population study from southeast Texas.

Suarez-Zambrano GA, Pena JA, Avila M, Hutton GJ, Rivera VM

Hemidystonia-hemiatrophy syndrome.

Wijemanne S, Jankovic J

The relationship between cognitive functioning and whole brain diffusion tensor imaging abnormalities in Parkinson's disease.

York MK, Karmonik C, Grossman RG, Wilde E

The relationship between diffusion tensor tractography and cognitive functioning in Parkinson's disease.

York MK, Karmonik C, Yallampalli R, Chu Z, Grossman RG, Wilde E

The self-management to prevent stroke clinic: teaching, translational research and technology.

Anderson JA, Willson P

A case of FSH?

Ansari S, Biliciler S, Mytu S, Harati Y

A case of Ehlers-Danlos.

Biliciler S, Smyth S, Harati Y

Progressive ascending weakness in an acquired immunodeficiency syndrome patient.

Kung D, Kuo S-H, Kwan J

Peau d’Orange skin changes and muscle weakness.

Kuo S-H, Kung D, Kwan JY

Diffuse painful muscle spasms.

Satija P, Clark G, Killian J

Why does my patient have camptocormia?

Smyth S, Biliciler S, Kwan J, Harati Y

A 25-year-old female with weakness and hearing loss: Charcot-Marie Tooth disease and deafness.

Yaltho TC, Grogan P, Jackson C

Increases in the excitability of CA1 pyramidal neurons after transient cerebral ischemia.

Fan Y, Deng P, Wang Y-C, Lu H-C, Xu ZC, Schulz PE

Is diabetes mellitus a protective factor for ALS?

Salamone AR, Wheaton M, McDowell E, Strutt AM, Schulz PE

Masking epilepsy by combining two epilepsy mutations.

Glasscock E, Qian J, Yoo JW, Noebels JL

Epileptic auras and the outcome of temporal lobectomy.

Gullapalli B, Cavazos JE, Yaltho TC, Mayes BN, Szabo CA

One-year outcome of resective epilepsy surgery.

Yaltho TC, Gullapalli BS, Mayes BN, Cavazos JE, Szabo CA

Wernicke's encephalopathy in cancer patients: A case series from MD Anderson cancer center.

Kuo SH, Debnam M, Fuller G, de Groot JF

Stroke secondary prevention: an exemplar for the chronic care model.

Anderson J

Gender differences in the clinical presentation of familial frontotemporal dementia.

Salamone AR, Strutt AM, McDowell EJ, Ngo D, Coerver K, Ringholz G, York MK, Schulz PE

Multiple sclerosis and antiphospholipid syndrome: Case report.

Avila M, Ramirez J, Suarez-Zambrano GA, Hutton GJ, Rivera VM

Encefalomielitis diseminada recurrente y multifásica reporte de 2 casos.
[Recurrent Disseminated Encephalomyelitis: Report of 2 Cases]

Avila M, Suarez-Zambrano GA, Ramirez J, Hutton GJ, Rivera VM

Experience with natalizumab in a group of ms patients from southeast Texas.

Suarez-Zambrano GA, Escobar BH, Avila M, Ramirez J, Hutton GJ, Rivera VM

Recurrent disseminated encephalomyelitis: Report of 2 cases.

Hutton GJ, Avila M, Suarez-Zambrano GA, Ramirez J, Rivera VM

Is restless legs syndrome more frequent and severe in the multiple sclerosis population? Study in multiple sclerosis patients from southeast Texas.

Hutton GJ, Suarez-Zambrano GA, Jafree I, Landero S, Avila M, Rivera VM

Daily energy expenditure and physical activity measured in Parkinson's disease patients with and without weight loss.

Delikanaki-Skaribas E, Trail M, Wong WW, Lai EC

Exposure to anti-dementia drugs slows clinical progression of Alzheimer's disease (AD).

Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Gulley A, Doody RS

Behavioral and cognitive dysfunction in amyotrophic lateral sclerosis.

Salamone AR, Witgert M, Strutt AM, Schulz PE

Experiencia con natalizumab en 40 pacientes con esclerosis multiple exacerbacion remision.

Suarez-Zambrano GA, Avila M, Landero S, Jafree I, Escobar BH, Ramirez J, Brandt D, Hutton GJ, Rivera VM

Real world response to Katrina.

Lockhart MC, Anderson JA

FTD-like cognitive and behavioral changes in ALS.

Salamone AR, Witgert M, Macias A, Massman P, Bradshaw M, Mosnik D, Schulz PE

Preliminary validation of the ALS Cognitive Behavioral Screen (ALS-CBS)™.

York MK, Macias A, Schulz PE, Harati Y, Katz J, Woolley-Levine S

Results of a one-year randomized, placebo-controlled trial of dimebon for the treatment of mild to moderate Alzheimer's disease.

Doody R, Garrilova S, Sano M, Thomas R, Aisen P, Bachurin S, Seely L, Hung D

Lipitor's effect in Alzheimer's dementia (LEADe) study: Baseline characteristics.

Jones R, Doody R, Sparks DL, Feldman H, Kivipelto M, Breazna A, Sovei M, DeMicco D, Hey-Hadavi J

Clinical factors associated with the preprogression rate (PPR) in Alzheimer's disease (AD).

Rountree SD, Pavlik VN, Chan W, Darby EJ, Doody RS

The dementia and disability in Thai elderly project: Prevalence of mild cognitive impairment with one-year follow-up and the prevalence of dementia in community-dwelling Thai elderly.

Senanarong V, Hamphadungkit K, Poungvarin N, Cummings J, Doody R

Rotigotine transdermal patch as a treatment of nocturnal symptoms in patients with idiopathic Parkinson's disease.

Chaudhuri KR, Jankovic J, Trenkwalder C, Boroojerdi B

Clinimetric testing of the new UPDRS (MDS-UPDRS) vs. original version.

Goetz CG, Tilley BC, Shaftman S, Stebbins GT, Fahn S, Martinez-Martin P, et al.

Clinical features of movement disorders in hemochromatosis.

Hall DA, Ringel S, Howard K, Jankovic J

Correlations of initial mentation rating in UPDRS and progression of motor and cognitive functions in Parkinson's disease.

Hou JG, Lai EC

Deep brain stimulation for tardive dyskinesia and akathisia.

Kenney C, Barbano R, Sheffield KJ, Jankovic J

Health related quality of life in essential tremor patients undergoing deep brain stimulation.

Kenney C, Diamond AL, Davidson A, Shinawi LM, Jankovic J

Health related quality of life in Parkinson's disease patients undergoing deep brain stimulation.

Kenney C, Diamond AL, Davidson A, Shinawi LM, Jankovic J

Parkinson's disease, malignant melanoma and body mass index.

Lai EC, Moore S

Switch from an oral dopamine agonist to rotigotine transdermal patch in Parkinson's disease.

LeWitt PA, Patton JM, MacMahon DG, Jankovic J

Ambulatory monitoring of freezing of gait in Parkinson's disease.

Moore ST, MacDougall HG, Ondo WG

Safety of concomitant therapy with rasagiline and antidepressants in Parkinson's disease.

Panisset M, Schwid S, Ondo W, Fitzer-Attas C, Chen JJ

Motor and behavioral outcomes after bilateral GPi deep brain stimulation for severe Tourette syndrome.

Shahed J, Poysky J, Kenney C, Simpson R, Jankovic J

Microlesion effects and tremor outcomes in ventrointermediate deep brain stimulation.

Sitburana O, Almaguer M, Ondo W

Weight change in parkinson and alzheimer patients taking atypical antipsychotic drugs.

Sitburana O, Rountree S, Vuong KD, Ondo W

Shoulder pain in Parkinson's disease.

Stamey W, Jankovic J

The other Babinski sign in hemifacial spasm.

Stamey W, Jankovic J

Influence of red and green laser lights on freezing of gait (FOG) in persons with Parkinson's disease (PD).

Suteerawattananon M, Rintala DH, Lai EC, Hou JG, Protas EJ

The specificity and sensitivity of "applause sign" in differentiating PSP and other parkinsonian syndromes.

Wu J, Sitburana O, Jankovic J

Brain permeable iron chelators M-30 and AK-28 rescue degenerated nigral dopamine neurons in animal model of PD.

Zhu W, Pan T, Xie W, Jankovic J, Zheng H, Youdim M, Le W

Multiple sclerosis and other autoimmune diseases.

Jafree I, Hashmi K, Landero S, Suarez G, Hutton GJ, Rivera VM

Behavior of multiple sclerosis during pregnancy and after delivery.

Landero S, Rivera VM, Hutton GJ, Suarez-Zambrano GA, Ramirez J

A phase II study of high-dose immunosuppressive therapy (HDIT) using carmustine, etoposide, cytarabine, and melphalan (beam) + thymoglobulin, and autologous CD34+ hematopoietic stem cell transplant (HCT) for the treatment of poor prognosis multiple sclero

Nash R, Openshaw H, Bowen JD, Forman SJ, Stuve O, Hutton GJ, Popat U, Wundes A, Kraft G

Frequency and severity of restless legs syndrome in ms patients from southeast Texas.

Suarez-Zambrano GA, Landero S, Jafree I, Hutton GJ, Rivera VM

Multiple sclerosis in African Americans: A cohort from southeast Texas.

Suarez-Zambrano GA, Landero S, Jafree I, Hutton GJ, Rivera VM

Computer-assisted cognitive rehabilitation in patients with multiple sclerosis.

Suarez-Zambrano GA, Perez F, Avila M, Hutton GJ, Rivera VM

Malignant Tourette syndrome.

Cheung MC, Shahed J, Jankovic J

Recovery of cerebral hemodynamics induces normalization of atypical ipsilateral motor activity on fMRI.

Chmayssani M, Barnes A, Handy C, Hirsch J, Marshall RS

Results of the Avonex Combination Trial (ACT).

Cohen J, Calabresi P, Eickenhorst T, Edwards K, Felton W, Fisher E, Fox R, Goodman A, Hara-Cleaver C, Hutton G, Imrey P, Mandell B, Scott T, Zhang H

Three parkin mutations in a family with Parkinson's disease.

Deng H, Le W, Shahed J, Jankovic J

Dimebon improves cognition, function, and behavior in patients with mild- moderate Alzheimer's disease: Results of a randomized, double-blind, placebo-controlled study.

Doody R, Gavrilova S, Sano M, Thomas R, Aisen P, Seely L, Hung D

The severity of mentation rating score is correlated with gait / balance scores in UPDRS for patients with Parkinson's disease.

Hou JG, Lai EC

Autopsy-proven Huntington disease with 29 trinucleotide repeats.
[Previously Presented]

Kenney C, Powell S, Jankovic J

Parkinson's disease and melanoma in a veteran population.

Lai EC, Moore S

Autophagy induction and its neuroprotection on neurotoxin-induced cell injury relevant to Parkinson's disease.

Pan T, Li X, Zhu W, Xie W, Jankovic J, Le W

Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis: The RENEW study.

Rivera VM, Al-Sabbagh A, Bennett R, Coyle P, Mikol D, Panitch H, Fox E, Rolak L, Sheremata W, Elias S

Motor overflow, contralateral dystonia and mirror movements in focal hand dystonia.

Sitburana O, Wu LJC, Sheffield KJ, Davidson A, Jankovic J

Head injury with amnesia and risk of multiple system atrophy (MSA).

Tanner C, Kukrull W, Shults C, Comyns K, Bhudhikanok G, May S, Goldman S, Meng C, Gilman S, Chade A, Kasten M, Colcher A, Huang N, Jankovic J, Low P, Marshall F, Novak P, Ondo W, Racette B, Reich S, Sandroni P, Stern M, Wooten GF

Novel brain permeable iron chelators prevent lactacystin induced ubiquitn-proteasome inhibition and degeneration of nigrostrialtal dopamine neurons.

Zhu W, Pan T, Xie W, Xu P, Zheng H, Fridkin M, Jankovic J, Youdim MBH, Le W

Proteasome inhibition in substantial nigra induces sustained dopamine cells degeneration.

Zhu W, Pan T, Zhang X, Xie W, Jankovic J, Le W

Design and baseline data for a study of Lipitor's effect in Alzheimer's disease (LEADe).

Feldman H, Sparks L, Doody R, Kivipelto M, Jones R, Sovel M, Breazna A, Hey-Hadavi J

Comparison of neuroprotective and neurorescue capabilities of rasagiline and selegiline, against lactacystin induced nigrostriatal degeneration.

Zhu W, Pan T, Xie W, Xu P, Jankovic J, Youdim MBH, Le W

Unusual cause of rhabdomyolysis.

Biliciler S, Harati Y, Kwan J, Lindsay A

Progressive muscle weakness and joint contractures.

Kwan J, Harati Y

Recurrent compartment syndrome.

Lindsay A, Harati Y, Kwan J, Biliciler S

It’s snowing! Seven cases of persistent migrainous visual aura.

Pacheco VH, Chung SM

Does acetazolamide act in intra-axonal flow?

Pacheco VH, Selhorst JB, Chung SM

Development of child and parent report measures of subjective memory.

Chapieski L, Evankovich K, Collins R, Hiscock M

A functional MRI study of social cognition in amyotrophic lateral sclerosis.

Pinto-Patarroyo GP, Schmolck H, Wheaton MW, Mosnik D, Macias A, King-Casas B, Montague PR, Schulz PE

The relationship between frontal behavioral and cognitive changes in ALS.

Salamone AR, Mosnik D, Witgert M, Bradshaw M, Schulz PE

The dissociation of dysarthria from cognitive dysfunction in ALS.

Sterling L, Mosnik D, Salamone AR, Wheaton M, Appel S, Schulz PE

Executive function disorders and ALS: implications for intervention.

Sterling LE, Mosnik DM, Appel SH, Schulz PE

Coagulopathy is an independent predictor of in-hospital mortality in patients with acute subdural hematoma.

Suarez JI, Feen ES, Suri MFK, Bershad E, Mirabelli J, Lynch G, Selman WR

Angioplasty and stenting in symptomatic intracraneal stenosis.

Avila M, De la Maza M, Martinez Ponce de Leon A

Endovascular coil treatment for rupture and unrupture brain aneurisms.

Avila M, De la Maza M, Martinez Ponce de Leon A

Rehabilitación cognitiva asistida por computadora en pacientes con esclerosis múltiple.

Suarez-Zambrano GA, Perez F, Avila M, Hutton GJ, Rivera VM

Epidemiologic association of Parkinson's disease and melanoma.

Bertoni JM, Arlette JP, Fernandez HH, Frei K, Gordon MF, Hassan MN, Isaacson SH, Lew MF, Molho E, Ondo WG, Phillips TJ, Singer C, Sutton JP, Wolf Jr JE

Comparison of the prevalence and pattern of non-motor symptoms in Parkinson's disease in drug naive and treated patients using the NMSQuest.

Clayton LM, Naidu Y, Odin P, Martinez P, Sethi K, Schapira A, Bonuccelli U, Stocchi F, Rabey M, MacMahon D, MacPhee G, Forbes A, Ondo W, Tsubio Y, Chaudhuri KR

Examination of LRRK2 I2012T, G2019S, and I2020T mutations in patients with essential tremor.

Deng H, Le W, Davidson AL, Xie W, Jankovic J

The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor.

Diamond A, Shahed J, Jankovic J

Deep brain stimulation of the subthalamic nucleus on Parkinson's disease: Effects on quality of life.

Diamond AL, Vuong KD, Jankovic J

Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian population.

Hunter CB, Tan EK, Lee J, Shinawi LM, Fook-Chong S, Jankovic J

Hyperhidrosis due to thalamic deep brain stimulation in a patient with essential tremor.

Kenney C, Diamond AL, Jankovic J

Clinical features that distinguish psychogenic and essential tremor.

Kenney C, Diamond AL, Mejia N, Hunter CB, Jankovic J

Short-term effects of tetrabenazine on chorea associated with Huntington disease.
[Previously Presented]

Kenney C, Hunter CB, Davidson A, Jankovic J

Autopsy-proven Huntington disease with 29 trinucleotide repeats.

Kenney C, Powell S, Jankovic J

Assessment of locomotor response to levodopa in fluctuating Parkinson's disease.

Moore S, MacDougall H, Gracies J, Ondo W

International validation study of the first comprehensive unified nonmotor symptoms scale (NMSS) for Parkinson's disease (PD).

Naidu Y, Schapira AH, Martinez-Martin P, Sethi K, Odin P, Stocchi F, Ondo W, Olanow CW, Barone P, MacMahon D, MacPhee G, Forbes A, Rabey M, Breen K, Bowron A, Tluk S, Thomas S, Abe K, Williams A, Rye D, Chaudhuri KR

Comparison of weight gain in treatments for Tourette's syndrome: Tetrabenazine versus neuroleptics.

Ondo WG, Jong D, Davidson A

Zonisamide for essential tremor.

Ondo WG, Khan F

Predictors of impulsivity and reward seeking behavior with dopamine agonists.

Ondo WG, Lai D

Sodium oxybate for excessive daytime sleepiness in Parkinson's disease: A polysomnographic study.

Ondo WG, Perkins T, Swick T, Hull, Jr. KL, Jimenez JE, Pardi D

Withdrawal of visual feedback improves micrographia in Parkinson's disease.

Ondo WG, Satija P

Enhancement of autophagy and neuroprotection by rapamycin in lactacystin-induced injury of dopaminergic neurons.

Pan T, Kondo S, Zhu W, Xie W, Jankovic J, Le W

Executive dysfunction and comorbid conditions in Tourette syndrome.

Poysky J, Khan H, Krull K, Jankovic J

Craving sweets in Parkinson's disease.

Shahed J, Davidson A, Jankovic J

GPI deep brain stimulation for Tourette syndrome improves tics and psychiatric co-morbidities.

Shahed J, Poysky J, Kenney C, Simpson Jr RK, Jankovic J

Overflow, contralateral and mirror hand dystonia.

Sitburana O, Jankovic J

Tetrabenazine for hyperglcemic-induced hemichorea-hemiballismus.

Sitburana O, Ondo WG

Hemiparkinsonism-hemiatrophy syndrome.

Wijemanne S, Jankovic J

Runner's dystonia.

Wu LJC, Jankovic J

Different faces of hemifacial spasm: Etiological classification.

Wu LJC, Jankovic J

Relationship of MRI localization and cognition in DBS.

York MK, Wilde E, Simpson Jr RK, Jankovic J

Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation.

Zhao H, Zhu W, Pan T, Xie W, Ondo W, Le W

Examination of LRRK2 I2012T, G2019S, and I2020T mutations in patients with essential tremor.

Deng H, Le W, Guo Y, Hunter CB, Xie W, Huang M, Jankovic J

A Mexican pedigree with Parkinson's disease, essential tremor and bell's palsy associated with parkin but not HS1BP3 gene mutation.

Deng H, Le W, Hunter CB, Xie W, Mejia N, Jankovic J

Genetic analysis of the SLITRK1 gene in caucasian patients with Tourette syndrome.

Deng H, Le W, Xie W, Jankovic J

Deep brain stimulation of the subthalamic nucleus on Parkinson's disease: Effects on quality of life.
[Previously Presented]

Diamond AL, Vuong KD, Jankovic J

Medications associated with the onset of tardive dyskinesia.

Hunter CB, Kenney K, Mejia N, Davidson A, Jankovic J

Short-term effects of tetrabenazine on chorea associated with Huntington disease.

Kenney C, Hunter CB, Davidson A, Jankovic J

Recurrent myelitis asociated with hepatitis C infection.

Pacheco VH, Acharya J

Weight change in Parkinson's disease patients taking atypical antipsychotics.
[Previously Presented]

Sitburana O, Ondo WG

An open randomized comparative study of clinical efficacy and safety of Huperzine A and Rivastigmine in treatment of Alzheimer disease.

Wu YC, Zhao YB, Xie YY

Family with female predominant FTD.

Salamone AR, McDowell E, York MK, Macias A, Ngo D, Mosnik D, Patel P, Coerver K, Ringholz G, Schulz PE

Stable suppression of Nurr1 gene using siRNA expression vector in a mouse midbrain dopaminergic cell line.

Wu YC, Zhao YB, Cai YQ, Fei J

Ion channel gene interactions in inherited epilepsy.

Glasscock E, Yoo J, Noebels JL

Predicting progression and survival in Alzheimer's disease.

Doody R, Pavlik V, Massman P, Rountree S, Waring S, Darby E, Chan W

Is functional decline necessary for a diagnosis of Alzheimer's disease?

Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS

Clinically presenting mild cognitive impairment (MCI): Variable presentations and their outcomes.

Rountree SD, Waring SC, Chan W, Darby EJ, Doody RS

Preprogression rate, cardiovascular comorbidity, and survival in Alzheimer's disease.

Waring SC, Paranilam JM, Doody RS, Darby EJ, Massman PJ, Chan W

Moving fingers, moving toes: A heterogeneous entity.

Pacheco VH, Hayat GR

Endovascular coiling for ruptured and unruptured intracranial aneurysms.

Avila M, De la Maza M, Martinez Ponce de Leon A

Intracranial angioplasty and stenting for symptomatic and asymptomatic intracranial stenosis.

Avila M, De la Maza M, Martinez Ponce de Leon A

International validation of the first unified Non Motor Symptoms Scale for Parkinson's disease. Results from the first pilot NMSS study.

Chaudhuri KR, Martinez-Martin P, Schapira AHV, Sethi K, Ondo W, Stocchi F, Odin P, Brown R, the International PD Non Motor Group (PDNMG)

Rationale, design, and baseline data for the Avonex Combination Trial (ACT).

Cohen J, Calabresi P, Edwards K, Eickenhorst T, Felton W, Fisher E, Fox R, Goodman A, Hara-Cleaver C, Hutton G, Imrey P, Mandell B, Scott T, Zhang H

Predicting progression of Alzheimer's disease.

Doody R, Pavlik V, Massman P, Rountree S, Darby E, Chan W

Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders.

Kenney C, Simpson Jr RK, Hunter CB, Ondo WG, Almaguer M, Davidson A, Jankovic J

Long term safety of deep brain stimulation for the treatment of Parkinson's disease.

Kenney CJ, Vuong K, Hunter C, Almaguer M, Jankovic J

Prevalence of Parkinson's disease in farming vs. non-farming counties in the US VHA population.

Lai EC, Moore S

Continuous assessment of gait via stride monitoring: a new approach to management of locomotor dysfunction in Parkinson's disease.

Moore ST, MacDougall HG, Cohen HS, Ondo WG

Nurrl deficiency predisposes to apoptosis induced by lactacystin in SH-SY5Y cells in vitro.

Pan T, Xie W, Deng H, Zhao H, Jankovic J

Bilateral GPI deep brain stimulation for Tourette syndrome.

Shahed J, Poysky J, Kenney C, Simpson Jr RK, Jankovic J

Weight change in Parkinson's disease patients taking atypical antipsychotics.

Sitburana O, Ondo WG

Frontostriatal cognitive functioning 6 months following bilateral subthalamic nucleus deep brain stimulation.

York MK, Jankovic J, Lai EC, Dulay M

The implication of glutamic acid decarboxylase autoantibodies in nystagmus: A case report.

Pacheco VH, Selhorst JB, Chung SM

Parkinson's disease: Demographic and geographic distribution of affected veterans (1998-2002).

Lai EC, Moore S

Progressive numbness and weakness in a diabetic patient: Is it all diabetic neuropathy?

Kwan J, Harati Y

Spontaneous mutilating acral ulcers in nondiabetic patients: The spectrum of differential diagnosis.

Kwan J, Harati Y, Phan C

Neuropsychological and demographic correlates of apraxia in a large cohort of Alzheimer's patients.

Acharya D, Massman P, Doody R

Phonemic cued performance on the Boston Naming Test: Longitudinal change and its correlates in Alzheimer's disease.

Benge J, Massman P, Jenkins R, Thornton G, Doody R

Neuropsychological outcome after bilateral deep brain stimulation surgery for advanced Parkinson's disease: Base rates adjusted for practice effects, test unreliability, and natural disease progression.

Dulay MF, York MK, Jankovic J, Simpson Jr RK

Naming improvement with phonemic cues: Which Alzheimer's patients benefit most?

Jenkins R, Massman P, Benge J, Thornton G, Doody R

Category-letter fluency discrepancies in healthy older adults: Normative data and reliability.

Thornton G, Massman P, Benge J, Jenkins R, Doody R

Verbal memory declines are largest for patients with depression and anxiety after anterior temporal lobectomy.

Dulay MF, Levin HS, York MK, Yoshor D, Grossman RG, Verma A, Goldsmith IL, Mizrahi EM

Impaired semantic memory in temporal lobe epilepsy - What is the role of anterior temporal lobectomy?

Schmolck H, York MK, Verma A, Goldsmith IL, Yoshor D, Levin HS, Foreman PJ, Mizrahi EM, Schulz PE

Identifying educational needs of interdisciplinary allied health professionals for Parkinson's disease care.

Nelson ND, Trail M, Lai EC

Semantic memory is more impaired in dominant than in nondominant temporal lobe epilepsy.

Schmolck H, Foreman PJ, Verma A, Goldsmith IL, York MK, Levin HS, Yoshor D, Mizrahi EM, Schulz PE

Intracranial angioplasty and stenting for symptomatic middle cerebral artery stenosis.

Avila M, Valderrama C, De la Maza M, Martinez Ponce de Leon A, Dondis D

The spectrum of clinical and radiological characteristics of acute disseminated encephalomyelitis.

De la Maza M, Escobar A, Rivera V, Dondis D, Avila M, Valderrama C

Caracterizacion de sindromes clinicos de comportamiento similar a esclerosis multiple.

Ordoñez L, Skromne E, Rivera-Olmos VM

Meta-analysis of 6-month memantine clinical trials in Alzheimer's disease.

Doody RS, Tariot PN, Pfeiffer E, Olin JT, Graham SM, Bell JM

Botulinum toxin type B Observational Study (BOS).

Jankovic J, Hunter CB, the BOS Study Group

The nurse's role in diagnosis and treatment of acute stroke.

Anderson J

The spectrum of clinical and radiological characteristics of acute disseminated encephalomyelitis.

Avila M, De la Maza M, Dondis D

Morbidity and mortality rate in carotid artery angioplasty and stenting.

Avila M, De la Maza M, Gonzalez Camid F, Martinez Ponce de Leon A, Dondis D, Valderrama C

Intracraneal angioplasty and stenting for symptomatic middle cerebral artery stenosis.

Avila M, De la Maza M, Martinez Ponce de Leon A, Dondis D

A novel approach in transitional cardiac rehabilitation.

Anderson J, Willson P

Videophone exercise motivation for peripheral arterial disease patients.
[Previously Presented]

Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

Meta-analysis of 6-month memantine clinical trials in Alzheimer's disease.

Doody RS, Tariot PN, Pfeiffer E, Olin JT, Graham SM, Bell JM

Donepezil and vitamin E in the progression of mild cognitive impairment to Alzheimer's disease: A hazard-ratio analysis.

Thal LJ, Thomas RG, Grundman M, Bennett DA, Doody RS, Ferris SH, Galasko DR, Jin S, Levey AI, Petersen RC

Videophone exercise motivation for peripheral arterial disease patients.
[Previously Presented]

Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

Application of the database as an historical control in experimental trials of proposed treatments for amyotrophic lateral sclerosis (ALS).

Czaplinski A, Haverkamp LJ, Yen AA, Lai EC, Appel SH

Genetic analysis of G309D and W4370PA mutations of PINK1 in Parkinson's disease.

Deng H, Le W, Zhang X, Pan T, Jankovic J

New version of the UPDRS: Development methods and working document for field testing.

Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins G, et al.

Early treatment with rasagiline is more beneficial than delayed treatment start in the long-term management of Parkinson's disease.

Hauser R, Lew M, Hurtig H, Ondo W, Wojcieszek J

A variant in the HS1-BP3 gene is associated with familial essential tremor.

Higgins JJ, Lombardi RQ, Pucilowska J, Jankovic J, Tan EK, Rooney JP

Mild cognitive impairment types and their outcomes.

Issa A, Rountree S, Waring S, Yeh S, Doody RS

Long-term efficacy of rasagiline in Parkinson's disease.

Lew M, Hauser R, Hurtig H, Ondo W, Wojcieszek J

ADAS-Cog change rates in MMSE Strata relevant to clinical trials.

Massman P, Doody RS

Convergence spasm and other psychogenic eye movement disorders.

Mejia NI, Jankovic J

Tics associated with other disorders.

Mejia NI, Jankovic J

HSP70 inducer VPA inhibits rotenone-induced apoptosis in SH-SY5Y cells.

Pan T, Xie W, Jankovic J, Le W

Relationship of premorbid IQ and education to progression of Alzheimer's disease.

Pavlik V, Doody RS, Massman P, Chan W, Yeh S

Characteristics of Parkinson's disease in patients with childhood-onset essential tremor.
[Previously Presented]

Shahed J, Diamond AL, Vuong KD, Jankovic J

Botulinum toxin treatment for oromandibular dystonia and bruxism in patients with Tourette syndrome.

Silay YS, Jankovic J

Brain attack - Time lost is brain lost.

Anderson J

Determining preoperative indicators for transitional cardiac rehabilitation after heart surgery.

Anderson J, Willson P

Videophone exercise motivation for peripheral arterial disease patients.

Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

Gait and balance assessment in parkinsonian disorders.

Azher SN, Vuong KD, Shahed J, Diamond AL, Jankovic J

An international multicentre study validating the first screening questionnaire (NMS-quest) for comprehensive assessment of non motor symptoms of Parkinson's disease.

Chaudhuri KR, Martinez-Martin P, Schapira AHV, Ondo W, Sethi K, Members of The PD NMS Scale Development Group

Small interfering RNA (SiRNA) targeting the PINK1 induces apoptosisin human SH-SY5Y cells.

Deng H, Jankovic J, Pan T, Xie W, Le W

Reduced NURR1 gene expression affects expression of dopaminergic phenotypic markers and Parkinson's disease-related genes.

Deng H, Jankovic J, Xie W, Pan T, Le W

Globus pallidus deep brain stimulation in dystonia.

Diamond AL, Shahed J, Azher SN, Vuong KD, Jankovic J

Relationship among psychiatric, motor and cognitive functioning in non-demented individuals with Parkinson's disease.

Dulay MF, Levin HS, Jankovic J, Lai EC, York MK

Tetrabenazine: Does prior history of depression preclude this drug as a treatment option?

Hunter C, Vuong KD, Mejia N, Jankovic J

Botulinum toxin type B Observational Study (BOS).

Jankovic J, Hunter C, Atassi MZ, Dolimbek BZ, Dolimbek GS, and BOS Research Group

Prevalence of cervical dystonia and spasmodic torticollis in the United States.

Jankovic J, Tsui J, Bergeron C

Medications associated with the onset of tardive dyskinesia.

Mejia N, Vuong KD, Hunter C, Jankovic J

A pilot study of the clinical efficacy and safety of memantine for Huntington's disease.

Mejia NI, Hunter C, Flores K, Ondo WG

Parkinson's disease and parkinsonism among us veterans: Demographic and geographic distribution in FY2002.

Moore S, Lai EC

Do Parkinson's disease caregiver proxy reports represent patient self-reports?

Nelson ND, Cook KF, Trail M, Lai EC

Specialty clinic for veterans with Parkinson's disease achieves high satisfaction.

Nelson ND, Fincher LR, Hou JG, Van JN, Lai EC

Paraspinal muscle asymmetry in Parkinson's disease.

Ondo WG, Haykal HA

The association between restless legs syndrome and essential tremor.

Ondo WG, Lai D

Predictors of battery life for the Activa® Soletra 7426 neurostimulator.

Ondo WG, Meilak C, Vuong KD, Jankovic J

Subthalamic deep brain stimulation in patients with a previous pallidotomy.

Ondo WG, Silay Y, Almaguer M, Jankovic J

Characteristics of Parkinson's disease in patients with childhood-onset essential tremor.

Shahed J, Diamond AL, Vuong KD, Jankovic J

Parkinsonism associated with adalimumab in a patient with rheumatoid arthritis.

Tintner R, Silay YS, Sessoms S, Jankovic J

Do patient outcomes predict caregiver depressive symptoms?

Trail M, Cook K, Nelson ND, Lai EC

Survival among veterans with Parkinson's disease.

White DL, Moore S, Lai EC

The effects of interferon-alpha and 13-cis retinoic acid on the cognitive function of adults with aggressive squamous cell carcinoma.

Collins RL, Lippman S, Meyers CA

Botulinum toxin serotype A compared to B in cervical dystonia: Randomized, double-blind, parallel study.

Comella CL, Jankovic J, Leurgans S, Fan W, Chmura T, the Dystonia Study Group

The safety of deep brain stimulation in patients with Parkinson's disease, essential tremor, and other movement disorders.

Silay Y, Jankovic J, Vuong KD, Almageur M, Ondo WG, Tintner R, Simpson Jr RK

Safety and efficacy of tetrabenazine in the treatment of Huntington's disease and other choreas.

Jankovic J, Hunter CB, Vuong KD

Donepezil is safe and well-tolerated in AD patients at doses of up to 20 mg/day.

Schindler R, Corey-Bloom J, Doody R, Zhang R, Leni JR, Li H

Functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease.

Wirth Y, Doody RS, Schmitt FA, Mobius HJ, Stoffler A

The spectrum of clinical and radiological characteristics of acute disseminated encephalomyelitis: Report of 3 cases.

Avila M, Dondis D, De la Maza M

Combinduction therapy with mitoxantrone and methylprednisolone for aggressive forms of multiple sclerosis in patients actively treated with large freacuent doses of interferon beta 1a.

Dondis D, Avila M, De la Maza M

Vascular dementia patients who receive donepezil treatment for 12 to 18 months maintain cognitive benefits.

Doody R, Pratt R, Posner H, Kumar D

Longitudinal analysis of the Alzheimer's Disease assessment scale in a large cohort of probable AD patients.

Massman P, Doody R

Memantine treatment for mild to severe Alzheimer's disease: Clinical trials summary.

Tariot P, Doody R, Peskind E, Winblad B, Reisberg B, Stoffler A, Graham S, McDonald S

Functional benefits of memantine treatment for patients with moderate to severe Alzhemier's disease.

Wirth Y, Doody RS, Schmitt FA, Mobius HJ

Memantine treatment is beneficial for functional capacities of patients with moderate to severe Alzheimer's disease.

Wirth Y, Doody R, Schmitt F, Mobius HJ, Stoffler A

Parkinson's disease: Demographic and geographic distribution of ICD-9 code 332.0 within the VHA.

Lai EC, Moore S, Hartman C

Tetrabenazine, a monoamine depleter, effective in the treatment of Tourette syndrome.

Hunter C, Vuong KD, Mejia N, Jankovic J

Tetrabenazine: Effective treatment for tardive dyskinesia.

Jankovic J, Hunter C, Mejia N, Vuong KD

A multicenter, double-blind, placebo-controlled trial of topiramate in essential tremor.

Jankovic J, Ondo WG, Stacy MA, Elble RJ, Pahwa R, Connor GS, Hulihan FJ, Schwarzman L, Wu SC

Nurr1 gene targeting therapy for Parkinson disease.

Le W, Jiang Q, Xie W, Hintermann S, Jankovic J

The pharmacological and biological effects of pramipexole on dopamine neuron associated genes: DAT, VMAT-2, and Nurr1.

Pan T, Xie W, Jankovic J, Le W

Young-onset versus late-onset Parkinson's disease: Clinical features and disease progression.

Silver GA, Vuong KD, Jankovic J

Long-term prognosis of psychogenic movement disorders.

Thomas M, Banuelos P, Vuong KD, Jankovic J

Psychogenic dystonia: Clinical characteristics and long-term progression.

Thomas M, Vuong KD, Jankovic J

A double-blind, randomized, parallel group design comparison of botulinum toxin, type A (Botox) and botulinum toxin, type B (Myobloc) on systemic and ocular autonomic symptoms and physiology in patients with cervical dystonia.

Tintner R, Gross RL, Winzer UF, Smalky KA, Jankovic J

Safety and efficacy of tetrabenazine in childhood hyperkinetic movement disorders.

Vuong KD, Hunter C, Mejia N, Jankovic J

Is depression a predictor of outcome after bilateral subthalamic deep brain stimulation in patients with Parkinson's disease?

York MK, Silay YS, Chaytor N, Simpson Jr RK, Jankovic J

Camptocormia: Pathogenesis, classification and response to therapy.

Azher S, Jankovic J

Genome-wide model-based and model-free linkage analyses co-localize a novel genetic locus on chromosome 9p for familial restless legs syndrome.

Chen S, Ondo WG, Rao S, Li L, Wang Q

Interim results of an observational study of neutralizing antibody formation with the current preparation of botulinum toxin type A treatment for cervical dystonia.

Comella CL, Jankovic J, Daggett S, Mordaunt J, Brin MF

Haplotype analysis at the ETM2 locus in American and Singaporean populations with familial essential tremor.

Higgins JJ, Lombardi RQ, Tan EK, Jankovic J, Pucilowska J, Rooney JP

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.

Hunter CB, Vuong KD, Jankovic J

Essential tremor in children.

Jankovic J, Madisetty J, Vuong KD

Psychogenic tremor: Long-term outcome.

Jankovic J, Vuong KD, Thomas M

Effects of ropinirole on progression of parkinsonism in Nurr1-deficient mice and its underlying mechanisms.

Jiang C, Pan T, Jankovic J, Le W

Dopaminergic properties and anti-parkinsonian effects of IPX750 in rodent models of Parkinson's disease.

Jiang C, Wan X, Jankovic J, Christian S, Sundsmo J, Le W

The north American survey of placement and adjustment strategies for deep brain stimulation.

Ondo WG, Bronte-Stewart H for the DBS Study Group

The pharmacological and biological effects of pramipexole on dopamine transporter.

Pan T, Jankovic J, Le W

Decreased Nurr1 mRNA in peripheral blood lymphocytes in Parkinson's disease.

Pan T, Xie W, Jankovic J, Le W

The efficacy and safety of fluphenazine in patients with Tourette syndrome.

Silay YS, Vuong KD, Jankovic J

A double-blind, randomized, parallel group design comparison of botulinum toxin, type A (Botox®) and botulinum toxin, type B (Myobloc™) on autonomic symptoms and physiology in patients with cervical dystonia.

Tintner R, Winzer UF, Smalky KA, Jankovic J

Temporal course of the motor effects of subthalamic DBS after stopping stimulation.

York MK, Lai EC, Soety EM, Atassi F, Grossman RG, Simpson Jr RK

Tetrabenazine in the treatment of chorea.

Jankovic J, Hunter CB, Vuong KD

Information processing speed influences the component processes of verbal working memory in Parkinson's disease patients.

York MK, Levin HS, Soety EM, Lai EC, Jankovic J, Grossman RG

Anterior thalamus interaction with the retrosplenial cortex in the anaesthetized rat.

Albo Z, Ding M, Vertes RP, Viana Di Prisco G

Seizure suppression in Drosophila.

Glasscock E, Tanouye MA

Coherence analysis of anterior thalamic unit firing with retrosplenial cortical and hippocampal theta rhythm.

Albo Z, Viana Di Prisco G, Ding M, Vertes RP

Donepezil-treated patients demonstrate global benefits on the Clinician's Interview-Based Impression of Change-Plus version: A comparison of Alzheimer's disease versus vascular dementia.

Doody RS, Pratt RD, Perdomo CA, the Donepezil 307 and 308 vaD Study Groups

Long-term treatment with the NMDA antagonist, memantine: Results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease.

Ferris SH, Schmitt FA, Doody RS, Moebius H-J, Stoeffler A, Reisberg BJ

Haplotype analysis of unrelated individuals with familial essential tremor.

Higgins JJ, Jankovic J, Lombardi RQ, Pucilowska J, Tan EK, Ashizawa T, Ruszczyk MU

Comparison of postoperative improvement of staged bilateral subthalamic stimulation in patients with advanced Parkinson's disease.

Kuniyoshi S, Tintner R, Ondo W, Simpson R, Jankovic J

Apolipoprotein E controls risk and age at onset of Parkinson disease.

Li Y-J, Martin ER, Scott WK, Haines JL, Nance MA, Hubble JP, Hiner BC, Jankovic J, Goetz CG, Small GW, Gibson RA, Middleton LT, Vance JM

Glutathione S-Transferase, Omega-1 (GSTO1) modifies age at onset of Alzheimer disease and Parkinson disease.

Li Y-J, Oliveria AS, Hauser MA, Hauser ER, Scott WK, Stenger JE, Hubble JP, Koller WC, Hiner BC, Jankovic J, Allen Jr FH, Roses AD, Saunders AM, Schmechel DA, Small GW, Gullans SR, Gilbert JR, Vance JM, Pericak-Vance MA

A double blind placebo controlled parallel trial of botulinum toxin B (Myobloc™) for the treatment of sialorrhea in parkinson disease.

Ondo WG, Hunter CB, Moore W

Long term treatment of restless legs syndrome with dopamine agonists.

Ondo WG, Romanyshyn J, Vuong KD

The epidemiology of myoclonus in the medical and surgical intensive care unit (ICU).

Tintner R, Kuniyoshi SM, Gonzalez A, Jankovic J

Specific mitochondrial haplogroups affect risk for late-onset Parkinson disease.

Van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Haines JL, McLaurin AC, Nance MA, Hubble JP, Koller WC, Padwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Small GW, Mastaglia F, Gibson RA, Middleton LT, Pericak-Vance MA, Vance JM

Improvement of spatial learning and memory after adenovirus-mediated transfer of the nerve growth factor gene to aged rat brain.

Yang K, Yuan X, Long Y, Lu H, Shine DH, Lai EC, Zou L

Dual-task functioning in mild and moderately severe Parkinson's disease patients.

York MK, Lai EC, Levin HS, Grossman RG

Norm-adjusted test scores among complicated mild head injury subtypes.

Collins RL, Hannay HJ, Cass J, Valadka A

The effects of IFN-alpha +13-CRA on patients with squamous cell carcinoma.

Collins RL, Lippman S, Meyers CA

When researchers in Parkinson's disease say, 'Quality of life,' what do they measure?

Cook KF, Nelson ND, Trail M, Willson P

Treatment of hypophonia with collagen vocal fold augmentation in patients with parkinsonism.

Hill AN, Jankovic J, Vuong KD, Donovan D

Age-related tolerability of tetrabenazine.

Hunter CB, Wang A, Vuong KD, Jankovic J

Tetrabenazine in the treatment of Tourette syndrome.

Hunter CB, Wang A, Vuong KD, Jankovic J

Premonitory sensations in tics.

Kwak CH, Jankovic J

Parkinson's disease and parkinsonism among Harris County veterans.

Lai EC, Waring S, Moore S

Reduced Nurr1 expression increases the susceptibility to dopaminergic toxins via nitric oxide.

Le W, Imam SZ, Xie W, Ali S, Jankovic J

Computerized posturography balance assessment of patients with bilateral vim deep brain stimulation.

Ondo WG, Cohen H, Almaguer M, Jankovic J

Evaluating factors that can influence spirography ratings in patients with essential tremor.

Ondo WG, Wang A, Thomas M, Vuong KD

Upregulation of Nurr1 gene expression by dopamine receptor agonist pramipexole in human neuroblastoma SHSY-5Y cells.

Pan TH, Xu PY, Xie WJ, Hunter C, Jankovic J, Le WD

Reliability of limits of stability measures in Parkinson's disease.

Protas EJ, Thomas M, Cunha IT, Caroline KS, Wankadia S, Jankovic J

Minocycline in Huntington's disease: A pilot study.

Thomas M, Ashizawa T, Jankovic J

Gait and Balance Scale (GABS): Validation and utilization.

Thomas M, Jankovic J, Suteerawattanon M, Wankadia S, Caroline K, Protas E

Experience with bilateral subthalamic nucleus (STN) stimulation for Parkinson's disease (PD).

Tintner R, Almaguer M, Sanghera M, Simpson R, Ondo WG, Jankovic J

Predictors of response to bilateral subthalamic nucleus stimulation for Parkinson's disease.

Tintner R, Almaguer M, Vuong KD, Ondo WG, Jankovic J, Sanghera M

Pleuropulmonary fibrosis after 11 years of pergolide treatment.

Tintner R, Manian P, Gauthier P, Jankovic J

The efficacy and safety of Dysport (botulinum type A toxin) in cervical dystonia: Results of the first US study.

Truong DD, Duane DD, Jankovic J, Singer C, Comella CL, the US Dysport Dystonia Study Group

Bone marrow stromal cell as potential cellular therapy for treatment of Parkinson's disease.

Yang K, Yuan X, Sun J, Long Y, Lai EC

Working memory functioning in mild and moderately severe Parkinson's disease patients.

York MK, Lai EC, Levin HS, Grossman RG

Dystonia in Friedreich's ataxia.

Hou JG, Jankovic J

Parkinson's disease among residents of Harris County, 1998.

Lai EC, Waring S, Moore S, Thompson M

How well do cerebral spinal fluid tau levels discriminate autopsy confirmed Alzheimer's disease from other dementia diagnoses?

Clark C, Eubank D, Peskind E, Galasko D, Morris J, McKeel D, Farlow M, Weitlauf S, Quinn J, Kaye J, Knopman D, Arai H, Doody R, Decarli C, Leight S, Lee V, Xie S, Trojanowski J

Pathogenesis and treatment strategies for selected therapies under development.

Doody RS

Long term treatment with the NMDA antagonist memantine: results of a 24-week, open label extension study in moderately severe to severe Alzheimer's disease.

Reisberg B, Mobius H, Stoffler A, Schmitt F, Doody R, Ferris S

Botulinum toxin A (Botox) for chronic daily headache: A randomized placebo-controlled, parallel design study.

Ondo WG, Vuong KD, Derman HS

Comparison of immunogenicity of old versus current Botox in cervical dystonia.

Jankovic J, Ahsan J, Vuong KD

Survival in patients with dementia from a large multi ethnic population.

Waring S, Doody RS

Neuropsychological test scores among complicated mild head injury subtypes.

Collins RL, Hannay HJ, Cass J, Valadka A

A study of neural interactions within the limbic system using partial coherence and direct transfer functions analysis.

Albo Z, Viana Di Prisco G, Truccolo W, Vertes RP, Ding M

Racial differences among patients with Alzheimer's disease from a large multi ethnic population.

Waring S, Doody RS

The prevalence of restless legs syndrome in patients with Parkinson's disease.

Atassi F, Vuong KD, Jankovic J, Ondo WG

The cognitive benefits of galantamine are sustained for at least 24 months: Results of a longterm extension trial in Alzheimer's disease.

Doody RS, Kershaw P

Exploring the relationship between Parkinson's disease and restless legs syndrome.

Ondo WG, Vuong KD, Jankovic J

Outcome of complicated mild head injury subtypes.

Hannay H, Collins R, Cass J, Valadka A

Dynamical theta resonance between anterior thalamus and retrosplenial cortex in the anesthetized rat.

Albo Z, Viana Di Prisco G, Vertes RP

Cholinesterase inhibitors: Benefits and limitations.

Doody RS

Olanzapine treatment for dopaminergic induced hallucinations.

Ondo WG, Hunter C, Vuong KD, Jankovic J

Daytime sleepiness in patients with Parkinson's disease.

Ondo WG, Vuong KD, Atassi F, Khan H, Kwak C, Jankovic J

Donepezil preserves activities of daily living in Alzheimer's disease patients: Results from a 1-year placebo-controlled functional survival study.

Mohs R, Doody R, Morris J, Ieni J, Perdomo C, Pratt R

Profoundly advanced Alzheimer's disease: Patient characteristics, functional status, disease progression, and care burden.

Sumaira R, Doody R, Lai EC

Unilateral thalamic deep brain stimulation for essential tremor and Parkinson's disease: Effects of stimulation on the non-target limb and rebound augmentation.

Vuong KD, Ondo WnG, Almaguer M, Simpson RK, Jankovic J

Uninterrupted long-term donepezil treatment results in optimal efficacy with retained safety.

Doody R, Geldmacher DS, Pratt RD, Perdoma CA

Re-entrant theta activity in Papez circuit: Role of the anterior ventral nucleus of the thalamus.

Albo Z, Viana Di Prisco G, Vertes RP

Kappa-opioid receptors in the substantia nigra pars reticulata mediate the U-50,488-induced locomotor activity of preweanling rats.

Collins RL, Zavala AR, Nazarian A, McDougall SA

Patterns of neuronal activity in the median raphe during hippocampal theta rhythm in the anesthetized rat.

Viana Di Prisco G, Albo Z, Vertes RP

Donepezil preserves functional status in Alzheimer's disease patients: Results from a 1-year placebo-controlled attrition study.

Mohs R, Doody R, Morris J, Ieni J, Rogers S, Perdomo C, Pratt R

Optimal donepezil efficacy in Alzheimer's disease is dependent on continued administration.

Doody RS, Geldmacher DS, Pratt RD, Perdomo CA

Does ApoE4 correlate with MRI changes in Alzheimer's disease?

Azher S, Doody RS, Haykal H, Dunn JK, Liao T-Y

Clinical benefits of donepezil: Results from a long-term phase III extension trial.

Doody RS, Pratt R, Perdomo C

Donepezil improves cognition and global function in Alzheimer's disease: Results from U.S. and multinational phase III clinical trials.

Petit H, Doody RS, Pratt R

Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease patients.

Doody RS, Clark C, Farlow M, Foster N, Gonzales N, Liao J, Lai E, Massman P

The presence of APO E4 does not influence rate of decline in Alzheimer's disease.

Kataki M, Doody RS, Liao J, Sims J

Current therapeutic standards in the treatment of Alzheimer's disease.

Doody RS

Research outcome measures in Alzheimer's disease: Statistical significance, effect size and responder analysis - How do they translate to clinical relevance?

Rogers S, Mohs R, Friedhoff L, Doody RS

Theta-rhythmic neuronal activity in anterior thalamic nuclei of the rat.

Kirk IJ, Albo Z, Vertes RP

Outcome measures in dementia trials-video CIBIC validity and reliability.

Quinn JF, Benson DF, Clark C, Doody RS, Jagust W, Knopman D, Kaye J

Donepezil HCI (E2020) improves cognitive and global function in patients with mild and moderately severe Alzheimer's disease: Results of a 15-week phase III study.

Rogers SL, Doody RS, Mohs RC, Friedhoff LT

Long lasting changes in cortical excitatory amino acid receptor levels and dopamine-induced behavior after neonatal excitotoxic lesions of the ventral hippocampus in rats.

Albo Z, Flores G, Barbeau D, Quirion R, Srivastava LK

Prevalence of uncontrolled hypertension in a population of Alzheimer's patients.

Kashani A, Doody RS, Wayner MJ, Phelix CF

Rate of dementia of the Alzheimer's type (DAT) in subjects with mild cognitive impairment.

Grundman M, Petersen R, Morris J, Ferris S, Sano M, Farlow M, Doody RS, Galasko D, Ernesto C, Thomas R, Thal L, the ADCS Cooperative Study

E-2020 Produces both clinical global and cognitive test improvement in patients with mild to moderately severe Alzheimer's disease (AD): Results of a 30-week phase III trial.

Rogers S, Doody RS, Mohs R, Friedhoff L

Pharmacologic evidence for autonomic psudomotor dysfunction in patients with Alzheimer's disease.

Sabbagh N, Smith RG, Lynn P, Doody RS, Appel SH, Killian JH

Reliability and validity of a new clinical global rating scale for Alzheimer's clinical trials.

Olin J, Clark C, Doody RS, Schmitt F, Ferris S, Morris J, Reisberg B, Sneider L

A new clinical global rating scale for Alzheimer's clinical trials.

Olin J, Schneider L, Clark C, Doody RS, Ferris S, Morris J, Reisberg B, Schmitt F

Cortical NMDA receptor levels are increased in adult rats following neonatal excitotoxic lesions of the ventral hippocampus.

Albo Z, Flores G, Barbeau D, Quirion R, Srivastava LK

Estrogen and psychomotor performance.

Doody RS, Young R, Lynn P, Cooke N, Rosenfield JE

A calculated measure to predict rate of progression in Alzheimer's disease.

Doody RS, Lynn P, Massman PJ

Sex differences involving naming in Alzheimer's disease: Stronger relationships with left hemisphere functioning in men.

Massman PJ, Doody RS

Psychometric profiles of Alzheimer's disease (AD) with/without white matter changes compared to subcortical ischemic vascular dementia (IVD).

Doody RS, Massman PJ, Nance ML

Neuropsychological distinctions between cortico-basal ganglionic degeneration (CBGD) and Alzheimer's disease with extrapyramidal signs.

Massman PJ, Kreiter KT, Jankovic J, Doody RS

Neuropsychological differentiation of corticobasal degeneration from Alzheimer's disease.

Massman PJ, Kreiter KT, Jankovic J, Doody RS

Dysfluency in the speech of AD patients.

Doody RS, Massman P

Literacy and cognition in northern Thailand.

Doody RS, Welsh K

Simulation analysis of a large British pedigree segregating a newly characterized autosomal dominant language disorder: Familial developmental dysphasia.

Dunn W, Doody RS, Gopnik M, Ashizawa T

Neuroimaging findings and clinical variables associated with psychosis in Alzheimer's disease.

Kotrla K, Chacko R, Jhingran S, Doody RS

Correlates of asymmetric motor speed in Alzheimer's disease.

Massman P, Doody RS

Neuropsychological correlates of apraxia in Alzheimer's disease patients.

Massman P, Doody RS

Positioning: Neurology and anthropology enabling practices.

Doody RS

Single photon emission computerized tomography (SPECT) in Alzheimer's disease and multiple-infarct dementia.

Doody RS, Strittmatter WJ, Jhingran S

Establishing the limits of the mini-mental state: MMS "subtests" versus a full neuropsychological battery.

Feher E, Mahurin R, Doody RS, Cooke N, Simms J, Pirozzolo F

Positive and negative psychiatric symptoms in Alzheimer's disease.

Mahurin R, Feher E, Doody RS, Inbody S

The alien hand and related signs.

Doody RS, Jankovic J

Sense and nonsense: Dissemination and empiricism in practice.

Doody RS

Recurrent posterior-type aphasia associated with a seizure focus.

Doody RS, Hrachovy RA

Progressive nonfluent aphasia.

Feher E, Doody RS, Whitehead J, Priozzolo F

Effects of stress management and dietary changes in treating ischemic heart disease.

Ornish DM, Scherwitz LW, Doody RS, et al.